Virginie Collas-Aubert

Virginie Collas-Aubert is a seasoned professional in regulatory affairs and quality assurance with extensive experience in the pharmaceutical industry. Currently serving as Senior Director of Regulatory Affairs and Chief Pharmaceutical Officer at Gilead Sciences since November 2017, Virginie manages a dedicated team overseeing regulatory activities. Prior to Gilead, Virginie held the position of International Regulatory Affairs Director at Vertex Pharmaceuticals, focusing on the launch of orphan drugs and advertising compliance. Virginie's experience includes a role as Quality & Compliance Director at Genzyme and significant responsibilities at Teva Pharmaceuticals, where key achievements included the launch of an average of 100 drugs per year and the registration of 50 marketing authorizations. Virginie holds a Doctorate in Pharmacy and a Certificate in Healthcare Compliance Ethics & Regulation from Sciences Po.